Trial Profile
A Randomized, Open Label, Single-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between DW330SR and DW1030 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Apr 2015
Price :
$35
*
At a glance
- Drugs Eperisone (Primary) ; Pelubiprofen (Primary)
- Indications Back pain; Fever; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Daewon Pharmaceutical
- 29 Mar 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
- 07 Mar 2014 New trial record